LABORATORIOS FARMACEUTICOS ROVI, S.A. «12345...» Page 1 out of 17 10/05/2024 10:02 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 2 May 2024 and 9 May 2024 Register number: 28591 08/05/2024 08:19 LABORATORIOS FARMACEUTICOS ROVI, S.A. Announcement of general shareholders’ meeting The Company announces the decision of its Board of Directors to convene the Ordinary General Shareholders' Meeting. Register number: 28499 30/04/2024 18:42 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information Share Buyback Program: transactions conducted between 26 April 2024 and 30 April 2024 Register number: 28405 26/04/2024 10:07 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 19 April 2024 and 25 April 2024 Register number: 28265 23/04/2024 11:07 LABORATORIOS FARMACEUTICOS ROVI, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 28144 19/04/2024 10:03 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 12 April 2024 and 18 April 2024 Register number: 28099 12/04/2024 10:45 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 5 April 2024 and 11 April 2024 Register number: 28001 05/04/2024 10:39 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 28 March 2024 and 4 April 2024 Register number: 27861 02/04/2024 07:03 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information The Company releases the press release related to the FDA’s approval of Risvan® (Risperidone ISM®) as a treatment for schizophrenia Register number: 27772 29/03/2024 09:32 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 22 March 2024 and 27 March 2024 Register number: 27758 Page 1 out of 17 «12345...»